NCT03446625View on ClinicalTrials.gov

Resveratrol as a Preventive Treatment of OHSS

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 13, 2018

Primary Completion Date

October 1, 2018

Study Completion Date

June 1, 2019

Conditions
Infertility
Interventions
DRUG

Resveratrol

Resveratrol treatment (2 g/day) will be administered for 9 days, starting from oocyte maturation day.

DRUG

Placebo

Placebo treatment (2 g/day) will be administered for 9 days, starting from oocyte maturation day.

Trial Locations (1)

28023

Ivi Madrid, Madrid

All Listed Sponsors
lead

IVI Madrid

OTHER

NCT03446625 - Resveratrol as a Preventive Treatment of OHSS | Biotech Hunter | Biotech Hunter